Adriamycin release from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles: Synthesis, and in vitro characterization

International Journal of Nanomedicine

Volumn 1, Issue 4, 2006, Pages 535-539

  Davaran, Soodabeh ^a   Rashidi, Mohammad R ^b   Pourabbas, Behzad ^c   Dadashzadeh, Mahin ^c   Haghshenas, Naser Moti ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c SAHAND UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Adriamycin; Cancer therapy; Drug delivery systems; PLGA PEG copolymers

Indexed keywords

DOXORUBICIN; DRUG CARRIER; MACROGOL DERIVATIVE; NANOPARTICLE; POLY(LACTIC GLYCOLIC ACID) POLY(ETHYLENEGLYCOL) COPOLYMER; POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER; POLYGLACTIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMISTRY; DIFFUSION; MATERIALS TESTING; PARTICLE SIZE; ULTRASTRUCTURE;

DIFFUSION; DOXORUBICIN; DRUG CARRIERS; MATERIALS TESTING; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLACTIN 910;

EID: 34548643298     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/nano.2006.1.4.535     Document Type: Article

References (21)

1. Avgoustakis K, Beletsi A, Panagi Z, et al. 2003. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm, 259:115-27.
2. Beletsi A, Leondiadis L, Klepetsanis P, et al. 1999. Effect of preparative variables on the properties of PLGA-mPEG copolymers related to their applications in controlled drug delivery. Int J Pharm, 182:187-97.
3. Beletsi A, Panagi Z, Avgoustakis K. 2005. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. IntJ Pharm, 298:233-41.
4. Birnbaum DT, Brannon-Peppas L. 2004. Microparticle drug delivery systems. In Brown DM (ed). Drug delivery systems in cancer therapy. Humana Press. p 117-35.
5. Eatock MM, Schätzlain A, Kaye SB. 2000. Tumor vasculature as a target for anticancer therapy. Cancer Treat Rev, 26:191-204.
6. Gref R, Minamitake Y, Peracchia MT, et al. 1994. Biodegradable long circulating polymeric nanosphers, Science, 263:1600-30.
7. Jeong Y, Nah JW, Lee HC, et al. 1999. Adriamycin release from flower-type polymeric micells based on star-block copolymer composed of poly(γ-Benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part, Int J Pharm, 188:49-58.
8. Kwon GS, Naito M, Yokoyama M, et al. 1995. Physical entrapment of adriamycin in AB block copolymer micelle. Pharm Res, 12:192-5.
9. Li YP, Pei YY, Zhang XY, et al. 2001. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release, 71:203-11.
10. Mitra S, Gaur U, Ghosh PC, et al. 2001. Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosane nanoparticles as carrier. J Control Release, 74:317-23.
11. Na K, Lee ES, Bae YH. 2003. Adriamycin loaded pulluan acetate/ sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependant cell interaction, internalization and cytotoxicity. J Control Release, 87:3-13.
12. Orive G, Hernández RM, Gasc AR, et al. 2005 Micro and nano drug delivery systems in cancer therapy. Cancer Ther, 3:131-8.
13. Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev, 55:329-47.
14. Peppas LB, Blanchette JO. 2004. Nanoparticle and targeted systems for cancer therapy. Adv Drug Del Rev, 56:1649-59.
15. Reynolds AR, Moghimi SM, Hodivala-Dilk K. 2003. Nanoparticle-mediated gene delivery to tumor vasculature. Trends Mol Med, 9:2-4.
16. Shikata F, Tokumitso H, Ichikava H, et al. 2002. In vitro cellular accumulation of gadolinium incorporated into chitosane nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm, 53:57-63.
17. Sledge G, Miller K. 2003. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur J Cancer, 39:1668-75.
18. Stubbs M, McSheely PMJ, Griffiths JR, et al. 2000. Causes and consequence of tumor acidity and implications for treatment. Mol Med Today, 6:15-19.
19. Tannock IF, Rotin D. 1989. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res, 49:4373-84.
20. Teicher BA. 2000. Molecular targets and cancer therapeutics: discovery, development and clinical validation. Drug Resist Updat, 3:67-73.
21. Yoo HS, Park TG. 2000. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. Polymer Prepr, 41:992-3.